Correlation between leukemic cell retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and response to therapy
- PMID: 282940
Item in Clipboard
Correlation between leukemic cell retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and response to therapy
Cancer Res.
1979 Jan.
No abstract available
Similar articles
-
Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.Cancer Res. 1980 Mar;40(3):588-91. Cancer Res. 1980. PMID: 6937239
-
Cellular pharmacology and optimal therapeutic concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic blasts during treatment of refractory leukemia with high-dose 1-beta-D-arabinofuranosylcytosine.Scand J Haematol Suppl. 1986;44:51-9. doi: 10.1111/j.1600-0609.1986.tb01590.x. Scand J Haematol Suppl. 1986. PMID: 3457439 No abstract available.
-
Degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human leukemic myeloblasts and lymphoblasts.Cancer Res. 1987 Jun 15;47(12):3130-5. Cancer Res. 1987. PMID: 3472653
-
Pharmacologically directed design of leukemia therapy.Haematol Blood Transfus. 1990;33:610-3. doi: 10.1007/978-3-642-74643-7_111. Haematol Blood Transfus. 1990. PMID: 2182451 Review.
-
Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.Cancer Res. 1977 Oct;37(10):3561-70. Cancer Res. 1977. PMID: 332337 Review. No abstract available.
Cited by
-
Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells.Neoplasia. 2008 Dec;10(12):1402-10. doi: 10.1593/neo.08972. Neoplasia. 2008. PMID: 19048119 Free PMC article.
-
Analysis of the drug synergism between thymidine and arabinosyl cytosine using mouse S49 T lymphoma mutants.Cancer Chemother Pharmacol. 1985;14(1):70-3. doi: 10.1007/BF00552729. Cancer Chemother Pharmacol. 1985. PMID: 3965162
-
Comparison of in vitro assays for detecting subpopulations of P388 leukemic cells resistant to AraC.Med Oncol Tumor Pharmacother. 1984;1(3):163-8. Med Oncol Tumor Pharmacother. 1984. PMID: 6544897
-
Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action.Clin Pharmacokinet. 2020 Dec;59(12):1521-1550. doi: 10.1007/s40262-020-00934-7. Clin Pharmacokinet. 2020. PMID: 33064276 Free PMC article. Review.
-
Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.J Clin Invest. 1985 Feb;75(2):632-42. doi: 10.1172/JCI111741. J Clin Invest. 1985. PMID: 3871794 Free PMC article.